RevolutionizingEmbryo Culture

"Oterus Bio began with the quiet grief my family experienced during our struggle to conceive. We were eventually successful, but the journey left us emotionally and financially devastated."

"In researching IVF, I discovered a heartbreaking reality: 62% of families drop out after 3–4 failed cycles. For many, the dream of parenthood is denied simply because they can no longer afford the gamble. This inequity is even more stark in minority communities; Black and Hispanic women are twice as likely to avoid IVF due to cost."

"Oterus was born from a passion to change this. We are developing technology to make IVF more predictable, efficient, and affordable. Our goal is to ensure that everyone has access to the most important experience of their lives. This isn't just a company; it is my mission to ensure no family has to walk away empty-handed."

"As a clinical embryologist, I have seen firsthand the heartbreak of failed IVF cycles. The uncomfortable truth is that over half of IVF cycles do not result in a healthy live birth. Why not? There are many reasons, but one critical factor is that embryo culturing occurs in an artificial environment. In vitro culturing often fails to replicate the nuances of the female reproductive tract, impeding the developmental and implantation competency of IVF-derived embryos."

"We can do better. At Oterus Bio, I bridge clinical embryology with human physiology to fix this "environment gap." By refining the microenvironment embryos experience in the lab, we ensure more embryos reach their full potential. My goal is to use my expertise to help families grow with fewer cycles and less emotional and financial cost. By improving the science of the culture, we are making the dream of a healthy live birth a reality for more families."

"I started this company because I've lived the heartbreak that so many IVF patients quietly carry. Across three IVF cycles, I retrieved 9–10 mature eggs each time, yet ended up with only three euploid embryos — including one cycle with none at all. Facing a roughly 10% euploid outcome was devastating, and it left me questioning how something so central to building a family could feel so unpredictable and out of our control. That question stayed with me."

"At the same time, I'm a bioengineer who has spent years developing biomaterials that mimic native biological environments. I've seen how profoundly cells respond when we recreate the cues they experience in the body, and I've long believed embryos deserve that same level of biological support. This company is where my personal IVF journey and my scientific training meet. By bringing biomimetic design into IVF, we aim to improve embryo quality and ease the emotional and financial burden for anyone fighting to build a family."